Syngene International Ltd Analyst Rating
based on 8 analysts
50.00%
Buy
0.00%
Hold
50.00%
Sell
Based on 8 analysts offering long term price targets for Syngene International Ltd. An average target of ₹862.5
Source: S&P Global Market Intelligence
Syngene International Ltd Share analysis
Syngene International Ltd price forecast by 8 analysts
Upside of0.10%
High
₹1030
Target
₹862.50
Low
₹700
Syngene International Ltd target price ₹862.5, a slight upside of 0.1% compared to current price of ₹861.6. According to 8 analysts rating.
Excluding Excise Duty and Other Income, represents Net Revenue
Syngene International Ltd revenue growth forecast
Expected growth rate Q1, FY2026:27.30%
Forecast
Actual
Including amortisation and stock based compensations
Syngene International Ltd EPS growth forecast
EPS estimate Q1, FY2026:32.62%
Forecast
Actual
Source: S&P Global Market Intelligence
Syngene International Ltd Performance
Day's Low
Day's High
₹856.8₹869.1552 Week's Low
52 Week's High
₹607.65₹945.25
| Returns % | |
| 1 Month Return | -2.77 % |
| 3 Month Return | + 3.69 % |
| 1 Year Return | + 19.55 % |
| Market Stats | |
| Previous Close | ₹862.75 |
| Open | ₹862.75 |
| Volume | 4.27L |
| Upper Circuit | - |
| Lower Circuit | - |
| Market Cap | ₹34,682.59Cr |
Syngene International Ltd Key Statistics
| P/E Ratio | 71.74 |
| PEG Ratio | -224.19 |
| Market Cap | ₹34,682.59 Cr |
| P/B Ratio | 6.73 |
| EPS | 12.69 |
| Dividend Yield | 0.18 |
| Sector | Healthcare |
| ROE | 11.95 |
Syngene International Ltd Peer Comparison
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
|---|---|---|---|---|---|---|
| HOLD | ₹34,682.59 Cr | 33.87% | 0.56 | ₹510 Cr | ₹3,488 Cr | |
| BUY | ₹14,230.58 Cr | -1.84% | 0.52 | ₹602 Cr | ₹2,851 Cr | |
| BUY | ₹73,183.73 Cr | 38.76% | 0.56 | ₹3,168 Cr | ₹29,001 Cr | |
| HOLD | ₹96,336.84 Cr | 59.29% | 0.64 | ₹3,854 Cr | ₹19,547 Cr | |
| BUY | ₹58,121.30 Cr | 22.68% | 0.53 | NA | NA |
Syngene International Ltd Mutual Fund Holdings
About Syngene International Ltd
Share Price: ₹861.60 per share as on 14 Nov, 2024 04:01 PM
Market Capitalisation: ₹34,682.59Cr as of today
Revenue: ₹891.00Cr as on September 2024 (Q3 24)
Net Profit: ₹106.10Cr as on September 2024 (Q3 24)
Listing date: 11 Aug, 2015
Chairperson Name: Kiran Mazumdar Shaw
| Organisation | Syngene International Ltd |
| Headquarters | |
| Industry | Healthcare |
| E-voting on shares | Click here to vote |
Key events for Syngene International Ltd
Positive Outlook for Syngene with Bull Spread Strategy - 08 Nov, 2024
HDFC Securities suggests a Bull Spread strategy for Syngene, highlighting strong short-term trends and technical indicators. Geopolitical shifts are also benefiting the company, though tangible outcomes may take time.
Syngene Reports Flat Q2 Performance with Recovery Signs - 30 Oct, 2024
Syngene International's Q2 performance was flat, with an EBITDA margin of 27%. Early recovery signs in Discovery Services are noted, driven by collaborations with biopharma clients. The company anticipates sequential growth and increased momentum in the coming quarters.
Karnataka High Court Extends Stay on Tree Clearing - 26 Oct, 2024
The High Court of Karnataka has extended the stay on orders from the National Highway Authority of India regarding tree clearing in the urban forest of Padua, affecting Syngene International and Vana Charitable Trust.
Syngene Reports Decline in September 2024 Sales - 24 Oct, 2024
Syngene International reported a decline in both consolidated and standalone net sales for September 2024, with profits and EBITDA also decreasing year-over-year. The stock closed at Rs 836.85 on October 22, 2024, reflecting a 19.37% return over the last six months.
Syngene Reports Q2 Results and Management Changes - 23 Oct, 2024
Syngene International reported a decline in Q2 revenue and profit, alongside significant management changes with Sibaji Biswas resigning as CFO. Deepak Jain will succeed him.
Insights on Syngene International Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTRevenue Rich
Revenue is up for the last 2 quarters, 839.8 Cr → 907.5 Cr (in ₹), with an average increase of 7.5% per quarter
- POSITIVE IMPACT
FII Holding Up
Foreign Institutions have increased holdings from 20.63% to 20.72% in Sep 2024 quarter
- POSITIVE IMPACT
Profit Spike
Netprofit is up for the last 2 quarters, 75.7 Cr → 106.1 Cr (in ₹), with an average increase of 28.7% per quarter
- POSITIVE IMPACT
Price Rise
In the last 6 months, SYNGENE stock has moved up by 25.5%
NO EFFECTAgainst Peers
In the last 3 years, Vimta Labs Ltd has given 119.3% return, outperforming this stock by 76.3%
- NO EFFECT
Against Peers
In the last 1 year, Vimta Labs Ltd has given 88.0% return, outperforming this stock by 68.5%
- NO EFFECT
Promoter Holding Unchanged
Promoters holdings remained unchanged at 54.72% of holdings in Sep 2024 quarter
NEGATIVE IMPACTRetail Holding Down
Retail Investor have decreased holdings from 7.42% to 6.74% in Sep 2024 quarter
- NEGATIVE IMPACT
MF Holding Down
Mutual Funds have decreased holdings from 13.63% to 13.58% in Sep 2024 quarter
Syngene International Ltd Financials
Index Inclusions
Syngene International Ltd Shareholding Pattern
| Investors | Holdings % | FY Quarter | 3M change |
|---|---|---|---|
| Promoter Holdings | 54.72% | 0.00 | |
| Foreign Institutions | 20.72% | 0.42 | |
| Mutual Funds | 13.58% | ||
| Retail Investors | 6.74% | ||
| Others | 4.24% | 18.11 |
Syngene International Ltd Key Indicators
Syngene International Ltd Valuation
Syngene International Ltd in the last 5 years
Lowest (23.09x)
March 31, 2020
Today (71.74x)
November 14, 2024
Industry (96.20x)
November 14, 2024
Highest (76.46x)
September 16, 2024
Syngene International Ltd Earnings and Dividends
Syngene International Ltd Earnings Results
Syngene International Ltd’s net profit fell -8.93% since last year same period to ₹106.10Cr in the Q2 2024-2025. On a quarterly growth basis, Syngene International Ltd has generated 40.16% jump in its net profits since last 3-months.
Read More about Earnings ResultsSyngene International Ltd Dividends April,2024
In the quarter ending March 2024, Syngene International Ltd has declared dividend of ₹1.25 - translating a dividend yield of 0.29%.
Read More about Dividends
Syngene International Ltd Technicals Summary
Bearish
Neutral
Bullish
Syngene International Ltd is currently in a Bearish trading position according to technical analysis indicators.
FAQs on Syngene International Ltd
- Get a PAN card.
- Open a Demat account.
- Open a Trading account.
- Link your Demat account to your Trading account.
- Fund your Trading account.
- Place an order to buy Syngene International Ltd shares.
Syngene International Ltd (SYNGENE) share price today is ₹861.6
Syngene International Ltd is listed on NSE
Syngene International Ltd is listed on BSE
- Today’s highest price of Syngene International Ltd is ₹869.15.
- Today’s lowest price of Syngene International Ltd is ₹856.8.
PE Ratio of Syngene International Ltd is 71.74
PE ratio = Syngene International Ltd Market price per share / Syngene International Ltd Earnings per share
Today’s traded volume of Syngene International Ltd(SYNGENE) is 4.27L.
Today’s market capitalisation of Syngene International Ltd(SYNGENE) is ₹34682.59Cr.
| Syngene International Ltd(SYNGENE | Price |
|---|---|
52 Week High | ₹945.25 |
52 Week Low | ₹607.65 |
Syngene International Ltd(SYNGENE) share price is ₹861.6. It is down -8.85% from its 52 Week High price of ₹945.25
Syngene International Ltd(SYNGENE) share price is ₹861.6. It is up 41.79% from its 52 Week Low price of ₹607.65
| Syngene International Ltd(SYNGENE | Returns |
|---|---|
1 Day Returns | -1.15% |
1 Month Returns | -2.77% |
3 Month Returns | 3.69% |
1 Year Returns | 19.55% |